Literature DB >> 9512650

Hepatic responses to inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase: a comparison of atorvastatin and simvastatin.

J D Bergstrom1, R G Bostedor, D J Rew, W M Geissler, S D Wright, Y S Chao.   

Abstract

We have compared the cellular responses to simvastatin (Simva) and atorvastatin (Atorva), two potent HMG-CoA reductase inhibitors. The two drugs exhibited similar IC50's for inhibition of either rat or human reductase, and single oral dosing in rats showed the compounds to be nearly equipotent at inhibiting hepatic cholesterol synthesis. Treatment of rats with Simva or Atorva in the feed for four days yielded comparable inductions of hepatic reductase activity and reductase protein. For example, 0.05% Simva induced reductase activity 27.3 +/- 9.1 fold and 0.05% Atorva induced activity 26.9 +/- 4.7 fold. This adaptive response was also studied in HepG2 cells, a human hepatoblastoma line, cultured for 24 h in delipidated serum and then for an additional 24 h with Simva or Atorva. Over a broad range (10 nM-10 microM), both drugs caused similar inductions of reductase activity, reductase protein, and reductase mRNA. Under all conditions, the drugs induced similar changes in the ratio of mRNA/protein suggesting that Simva and Atorva have similar effects on both transcriptional and post-transcriptional regulatory machinery. Moreover, reductase in cells treated with Simva or Atorva for 22 h responded similarly to subsequent challenge with 25-hydroxycholesterol. Finally, we measured the ability of the two reductase inhibitors to reduce ApoB secretion by HepG2 cells. Simva and Atorva at 0.5 microM inhibited ApoB secretion nearly identically, 38% and 42% respectively. We conclude that these two drugs induce similar adaptive responses in cells and that their actions are qualitatively and mechanistically identical. Human studies have shown that plasma is cleared of Atorva much more slowly than it is of Simva. The large pharmacokinetic difference in man, rather than some difference in mechanism, is the most likely explanation for the finding that the equipotent dose ratio for cholesterol lowering in humans of Simva to Atorva is about 2/1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512650     DOI: 10.1016/s0005-2760(97)00182-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig.

Authors:  K Conde; S Roy; H C Freake; R S Newton; M L Fernandez
Journal:  Lipids       Date:  1999-12       Impact factor: 1.880

2.  Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice.

Authors:  Marleen Schonewille; Jan Freark de Boer; Laura Mele; Henk Wolters; Vincent W Bloks; Justina C Wolters; Jan A Kuivenhoven; Uwe J F Tietge; Gemma Brufau; Albert K Groen
Journal:  J Lipid Res       Date:  2016-06-16       Impact factor: 5.922

3.  Differential and kinetic effects of cell cycle inhibitors on neoplastic and primary astrocytes.

Authors:  Veetai Li; Thomas J Langan; Kyla R Rodgers; Richard C Chou
Journal:  Cell Cycle       Date:  2016-08-11       Impact factor: 4.534

4.  Impact of dietary fat type within the context of altered cholesterol homeostasis on cholesterol and lipoprotein metabolism in the F1B hamster.

Authors:  Jaime L Lecker; Nirupa R Matthan; Jeffrey T Billheimer; Daniel J Rader; Alice H Lichtenstein
Journal:  Metabolism       Date:  2010-03-02       Impact factor: 8.694

5.  Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.

Authors:  Jesus A Villanueva; Anna Sokalska; Amanda B Cress; Israel Ortega; Kaylon L Bruner-Tran; Kevin G Osteen; Antoni J Duleba
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

6.  Simvastatin induces cell death in a mouse cerebellar slice culture (CSC) model of developmental myelination.

Authors:  Zhongmin Xiang; Steven A Reeves
Journal:  Exp Neurol       Date:  2008-09-27       Impact factor: 5.330

7.  Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis.

Authors:  Anna Sokalska; MariaPia Anderson; Jesus Villanueva; Israel Ortega; Kaylon L Bruner-Tran; Kevin G Osteen; Antoni J Duleba
Journal:  J Clin Endocrinol Metab       Date:  2013-01-21       Impact factor: 5.958

8.  Statin-dependent modulation of mitochondrial metabolism in cancer cells is independent of cholesterol content.

Authors:  Charleston F Christie; Diana Fang; Elizabeth G Hunt; Morgan E Morris; Amandine Rovini; Kareem A Heslop; Gyda C Beeson; Craig C Beeson; Eduardo N Maldonado
Journal:  FASEB J       Date:  2019-04-05       Impact factor: 5.834

9.  Camphene, a Plant Derived Monoterpene, Exerts Its Hypolipidemic Action by Affecting SREBP-1 and MTP Expression.

Authors:  Ioanna Vallianou; Margarita Hadzopoulou-Cladaras
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

10.  A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats.

Authors:  Sarai Rodríguez; Imma Raurell; Manuel Torres-Arauz; Teresa García-Lezana; Joan Genescà; María Martell
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.